APELLIS PHARMACEUTICALS |
USA |
Gesundheit |
US03753U1060 / A2JAAW |
1JK (Frankfurt) / APLS (NASDAQ) |
FRA:1JK, ETR:1JK, 1JK:GR, NASDAQ:APLS |
- |
https://www.apellis.com/ |
Apellis Pharmaceuticals Inc. is a biopharmaceutica..
>Volltext.. |
2979.66 Mio. EUR |
3063.05 Mio. EUR |
645.81 Mio. EUR |
-161.11 Mio. EUR |
-195.27 Mio. EUR |
-1.56 EUR |
402.02 Mio. EUR |
317.89 Mio. EUR |
3.84 Mio. EUR |
1.85 |
9.13% |
37.68% |
- |
- |
- |
APELLIS |
31.08.25 |
|